Yanfang Wang
- Topics
- CAR-T cell therapy research (6 papers)Cancer Immunotherapy and Biomarkers (6 papers)Advanced Drug Delivery Systems (5 papers)
- Journals
- Journal of the American Chemical SocietyAngewandte Chemie International EditionNature Communications
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yanfang Wang
30 papers receiving 570 citations
Peers
Comparison fields: 5 of 75
- Oncology 176
- Molecular Biology 174
- Immunology 98
- Biomedical Engineering 91
- Pharmaceutical Science 78
Countries citing papers authored by Yanfang Wang
This map shows the geographic impact of Yanfang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfang Wang more than expected).
Fields of papers citing papers by Yanfang Wang
This network shows the impact of papers produced by Yanfang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfang Wang. The network helps show where Yanfang Wang may publish in the future.
Co-authorship network of co-authors of Yanfang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yanfang Wang. A scholar is included among the top collaborators of Yanfang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfang Wang. Yanfang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 24 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 18 | |
| 11 | 20 | |
| 12 | 7 | |
| 13 | 19 | |
| 14 | 11 | |
| 15 | 19 | |
| 16 | 19 | |
| 17 | 4 | |
| 18 | 47 | |
| 19 | 17 | |
| 20 | 51 |
About Yanfang Wang
Yanfang Wang is a scholar working on Pharmaceutical Science, Oncology and Immunology, having authored 31 papers that have together received 577 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Advanced Drug Delivery Systems (5 papers). The work is most often cited by research in Pharmaceutical Science (78 citations), Oncology (176 citations) and Molecular Medicine (28 citations). Yanfang Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zhen Gu, Jinqiang Wang, Jicheng Yu, Yinxian Yang, Yuqi Zhang, Ruyi Zhou, Jaekwon Lee, Vinit Shanbhag, Michael J. Petris and Sha Zhu. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.